Life Science Accelerator Programme: How Cutting-edge Companies are Growing Organically at BioCity NottinghamAmy Cotterill2023-04-19T13:06:42+01:00April 17th, 2023|Accelerator, BioCity Nottingham, Investment, News|
Myconeos Innovate UK Smart Grant SuccessVicky Coghlan2023-03-28T14:48:14+01:00March 28th, 2023|BioCity Nottingham, News|
NanoSyrinx Joins Life Sciences Incubator in NottinghamAmy Cotterill2023-03-27T16:05:05+01:00March 27th, 2023|Accelerator, BioCity Nottingham, Investment, News|
Life Sciences Investment Showcase: Connecting Entrepreneurs with Expert Growth FacilitatorsAmy Cotterill2023-04-27T13:12:21+01:00March 23rd, 2023|Accelerator, Investment, News|
Five Questions With Harry Pickering, Portfolio Director & Head of UK InvestmentSteve Jarvis2023-04-03T14:06:03+01:00February 21st, 2023|Article, Headline Article, Investment|
Pioneer Group Tenant MIP Discovery Secure Funding From Bill & Melinda Gates FoundationSteve Jarvis2023-04-03T14:24:52+01:00February 16th, 2023|Colworth Park, News|
OMass Therapeutics Raises $100 million to Progress Drug Pipeline in Immunology and Rare DiseasesGemma Cann2022-06-30T11:29:35+01:00April 28th, 2022|BioCity Nottingham, News|
Invizius Awarded Second Biomedical Catalyst GrantGemma Cann2022-06-30T11:30:18+01:00April 26th, 2022|BioCity Glasgow, News|
Invizius Awarded Major Biomedical Catalyst GrantGemma Cann2022-06-30T11:33:29+01:00April 1st, 2022|BioCity Glasgow, News|
Phenotypeca Wins a Third Grant from Innovate UKGemma Cann2022-06-30T11:42:06+01:00February 17th, 2022|News|
